v3.26.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The Company’s pretax loss, disaggregated between domestic and foreign sources, is as follows:
Year Ended
December 31,
20252024
United States$(30,468)$(34,946)
International— — 
Loss before income taxes$(30,468)$(34,946)
Schedule of Effective Income Tax Rate Reconciliation
The following is a reconciliation of the statutory federal income tax rate to the Company’s effective tax rate:
(in thousands)Year Ended
December 31, 2025		Year Ended
December 31, 2024
Tax at U.S. statutory rate$(6,398)21.0 %$(7,297)21.0 %
State income taxes, net of federal benefit(1,453)4.8 %(811)2.3 %
Tax law changes8 — %— — %
Change in valuation allowance6,453 (21.2)%9,184 (26.4)%
Nondeductible items1,431 (4.7)%929 (2.7)%
Loss on extinguishment of debt1,239 894 
Legal contingencies166 — 
Fines and penalties14 33 
Stock-based compensation (ISOs)12 2 
Changes in unrecognized tax benefits— — %(2,015)5.8 %
Other items(41)0.1 %10 — %
$— — %$— — %
Schedule of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities are as follows:
(in thousands)December 31,
2025		December 31,
2024
Deferred tax assets:
Net operating loss carryforwards$60,915 $47,769 
Research and development credits4,842 4,842 
Capitalized research and development costs (including Section 59(e))8,953 15,306 
Start-up and organization costs15,351 16,530 
Stock-based compensation7,548 6,725 
Intangibles43 36 
Property and equipment394 257 
Operating lease liabilities1,871 241 
Total deferred tax assets before valuation allowance99,917 91,706 
Valuation allowance(98,078)(91,624)
Total deferred tax assets1,839 82 
Deferred tax liabilities:
Operating lease right-of-use assets
(1,839)(82)
Total deferred tax liabilities(1,839)(82)
Net deferred tax assets$— $—